Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

Abstract Background The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA) is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and autoantibodies could be involved in the pathogenesis of atherosclerotic disease. It has been suggested that anti-p...

Full description

Bibliographic Details
Main Authors: Sofia Ajeganova, Maria L. E. Andersson, Johan Frostegård, Ingiäld Hafström
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Arthritis Research & Therapy
Subjects:
Phosphorylcholine autoantibodies
Innate immunity
Cardiovascular events
Rheumatoid arthritis
Online Access:https://doi.org/10.1186/s13075-021-02581-0

Internet

https://doi.org/10.1186/s13075-021-02581-0

Similar Items